Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Indwelling Catheters Market size was valued at USD 1.27 Billion in 2024 and is poised to grow from USD 1.34 Billion in 2025 to USD 2.13 Billion by 2033, growing at a CAGR of 5.9% during the forecast period (2026–2033).

    The global indwelling catheters market presents a dynamic competitive landscape characterized by a multitude of established and emerging players striving to establish their prominence. Industry leaders are engaged in intensive research and development to introduce advanced catheter technologies that enhance patient comfort, minimize risks, and optimize clinical outcomes. Strategic collaborations, mergers, and acquisitions are prevalent strategies for market expansion, enabling companies to diversify their product portfolios, extend their geographic reach, and leverage combined expertise. 'Cardinal Health, Inc. (USA)', 'Coloplast Corp. (Denmark) ', 'Becton, Dickinson and Company (USA) ', 'Teleflex Incorporated (USA) ', 'Cook Medical (USA) ', 'Bactiguard (Sweden) ', 'SunMed (USA) ', 'B. Braun Melsungen AG (Germany) ', 'Medtronic PLC (Ireland) ', 'Hollister Incorporated (USA) ', 'Boston Scientific Corporation (USA) ', 'Smiths Medical (UK) ', 'ConvaTec Group PLC (UK) ', 'C. R. Bard, Inc. (USA) ', 'Rochester Medical Corporation (USA) ', 'Well Lead Medical Co., Ltd. (China) ', 'Fuji Systems Corporation (Japan) ', 'Teleflex Medical OEM (USA) ', 'AngioDynamics, Inc. (USA) ', 'Nipro Corporation (Japan)'

    The increasing incidence of urological disorders, such as urinary retention, bladder cancers, and benign prostatic hyperplasia, is driving the demand for indwelling catheters as an essential medical intervention.

    Material Advancements: Innovations in catheter materials, including the use of silicone and hydrophilic coatings infused with antimicrobial agents, are enhancing infection prevention and patient comfort.

    In the realm of regions, North America is poised to assume a substantial portion of the indwelling catheters market share. This estimation is based on the anticipation that North America will secure a commanding hold due to factors such as the escalating incidence of urological disorders—ranging from bladder cancers and benign prostatic hyperplasia to urinary retention—and a pronounced focus on propelling product development endeavors within the region.

    Feedback From Our Clients

    Global Indwelling Catheters Market

    Report ID: SQMIG35A2567

    $5,300
    BUY NOW